Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Testa, Marcia
PropertyValue
overview Dr. Testa and colleagues are developing quantitative and health information technology methods and processes relating to the measurement and analysis of expanded patient outcomes (quality of life, cost-effectiveness and risk-benefit) for clinical, pharmacoeconomic, pharmacoepidemiologic, quality of care and comparative effectiveness research studies with particular application to primary care, cardiovascular disease, HIV, and diabetes. Quality of Life, Patient Satisfaction, Clinical Decision Making and Comparative Effectiveness Research Dr. Testa is working on analytical, statistical and health information methods for conducting health outcomes and comparative effectivness research for pharmaceutical drug development, disease management, quality of care programs and primary care and physician subspecialty practice management. As part of this methodologic work, she is analyzing a comprehensive database of patients who have participated in large-scale clinical trials of antihypertensive and diabetes therapies to evaluate differential treatment effects on quality-of-life outcomes including mood, vitality, sleep, cognitive functioning, sexual dysfunctioning, work/social role functioning and physical symptoms. Dr. Testa is exploring the relationships between treatment satisfaction, glycemic control, hypo and hyperglycemic symptomatology, quality of life and health care utilization during the treatment of patients with type 1 and type 2 diabetes. For the past five years she also has worked on designing Web 2.0 and Health 2.0 home health monitoring health information systems involving the use of telemedicine and telehealth (e-Health) strategies for diabetes management. Pharmacoeconomics and Pharmacoepidemiology As part of the AIDS Clinical Trials Group, Dr. Testa and colleagues have evaluated the quality-of-life impact of treatment for HIV in medication adherence models. Adherence to HIV therapy has implications for the cost-effectiveness of new treatments. Dr. Testa is also currently developing database systems and electronic reporting devices (e-diaries) for monitoring health outcomes, expanding observational databases for longitudinal research and surveying resource utilization and costs for inclusion into pharmacoeconomic, pharmacoepidemiological and cost-effectivness models. She has guided doctoral research in the areas of health outcomes research and pharmacoepidemiology evaluating patient compliance, physician practice patterns and patient functional health status and quality of life using large patient information systems. Statistical Methods for Quality-of-Life Outcomes Research Dr. Testa and colleagues are developing more sophisticated methods for dealing with the analysis of expanded patient outcomes. The statistical and analytical issues involve applications of item response theory, causal modeling, latent variables and structural equation modeling to the analysis of quality-of-life and patient satisfaction data. Other topics of research interest include: measurement, involving the response structure of multi-dimensional constructs, intervention and non-intervention based validities, and respondent variability; hypothesis testing, including estimation of power, simultaneous test procedures, global hypothesis testing, longitudinal models, and the effects of missing data, early withdrawal, length bias and confounding; and overall effectiveness models, specifically quality-adjustment measures, and health state transition and utility models.
One or more keywords matched the following items that are connected to Testa, Marcia
Item TypeName
Academic Article Efficacy of low-dose interferon with antiretroviral therapy in Kaposi's sarcoma: a randomized phase II AIDS clinical trials group study.
Academic Article Educational attainment and response to HAART during initial therapy for HIV-1 infection.
Academic Article Lack of antitumor activity and intolerance of interleukin-4 in patients with advanced HIV disease and Kaposi's sarcoma.
Academic Article Four measures of antiretroviral medication adherence and virologic response in AIDS clinical trials group study 359.
Academic Article Assessing public health capabilities during emergency preparedness tabletop exercises: reliability and validity of a measurement tool.
Academic Article Development of a survey instrument to measure connectivity to evaluate national public health preparedness and response performance.
Academic Article The risk of hospitalized infection in patients with rheumatoid arthritis.
Concept Emergency Medical Services
Concept Dose-Response Relationship, Drug
Concept Emergencies
Concept Emergency Service, Hospital
Academic Article Index to Predict In-hospital Mortality in Older Adults after Non-traumatic Emergency Department Intubations.
Academic Article Symptom distress check lists as a component of quality of life measurement: Comparing symptom reports with responses to multiple choice questionnaires
Academic Article Ambulatory Medication Reconciliation and Frequency of Hospitalizations and Emergency Department Visits in Patients With Diabetes.
Academic Article Preparedness Emergency Response Research Centers (PERRCs): Addressing Public Health Preparedness Knowledge Gaps Using a Public Health Systems Perspective.
Grant TP10-1001, PREPAREDNESS AND EMERGENCY RESPONSE LEARNING CENTER (PERLC)
Search Criteria
  • Emergency
  • Response
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.